Hayek Kallen Investment Management Synaptogenix, Inc. Transaction History

Hayek Kallen Investment Management

  • $282 Million
  • Q3 2024

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 07, 2023
BUY
$0.28 - $1.04 $4,900 - $18,200
17,500 New
17,500 $8,000

Others Institutions Holding SNPX

# of Institutions
1
Shares Held
30K
Call Options Held
0
Put Options Held
0
View Full List

About Synaptogenix, Inc.

SNPX Quotes by TradingView
  • Ticker SNPX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 6,840,630
  • Market Cap $20.2M
  • Description
  • Synaptogenix, Inc. operates as a biopharmaceutical company with product candidates in pre-clinical and clinical development. It focuses on developing a product platform based upon a drug candidate called Bryostatin-1 for the treatment of Alzheimer's disease. The company is also evaluating therapeutic applications of bryostatin for other neurodeg...
More about SNPX
Track This Portfolio

Track Hayek Kallen Investment Management Portfolio

Follow Hayek Kallen Investment Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hayek Kallen Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Hayek Kallen Investment Management with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email